Do analysts rate HSAQ or NSPR?

InspireMD has a consensus price target of $4.50, indicating a potential upside of 411.36%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Health Sciences Acquisitions Co. 2. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 InspireMD 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has higher earnings and valuation, HSAQ or NSPR?

Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than InspireMD. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Health Sciences Acquisitions Co. 2 N/A N/A -$380K N/A N/A InspireMD $10.85M 3.80 -$19.92M -$0.73 N/A

Which has higher earnings and valuation, PETV or HSAQ?

Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than PetVivo. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PetVivo $1.05M 25.42 -$10.95M -$0.38 N/A Health Sciences Acquisitions Co. 2 N/A N/A -$380K N/A N/A

Which has preferable earnings and valuation, HSAQ or TMDIF?

Titan Medical has higher revenue and earnings than Health Sciences Acquisitions Co. 2. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Health Sciences Acquisitions Co. 2 N/A N/A -$380K N/A N/A Titan Medical $17.63M 1.13 $6.95M $0.05 3.50

Is HSAQ or TMDIF more profitable?

Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat Titan Medical's return on equity. Company Net Margins Return on Equity Return on Assets Health Sciences Acquisitions Co. 2 N/A N/A -2.38% Titan Medical N/A -82.31% -51.47%

Which has preferable earnings & valuation, HSAQ or RVP?

Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than Retractable Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Health Sciences Acquisitions Co. 2 N/A N/A -$380K N/A N/A Retractable Technologies $37.15M 0.55 -$7.01M -$0.21 N/A

Which has better earnings and valuation, LMNX or HSAQ?

Defiance Daily Target 2X Long LMND ETF has higher revenue and earnings than Health Sciences Acquisitions Co. 2. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Defiance Daily Target 2X Long LMND ETF $437.66M 0.01 $15.17M $0.51 20.73 Health Sciences Acquisitions Co. 2 N/A N/A -$380K N/A N/A

Health Sciences Acquisitions Co. 2 (HSAQ) Competitors

$3.90 -0.09 (-2.26%)

As of 06/5/2026

Compare

HSAQ vs. NSPR, PETV, TMDIF, RVP, and LMNX

Should you buy Health Sciences Acquisitions Co. 2 stock or one of its competitors? MarketBeat compares Health Sciences Acquisitions Co. 2 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Health Sciences Acquisitions Co. 2 include InspireMD (NSPR), PetVivo (PETV), Titan Medical (TMDIF), Retractable Technologies (RVP), and Defiance Daily Target 2X Long LMND ETF (LMNX). These companies are all part of the "medical" sector.

How does Health Sciences Acquisitions Co. 2 compare to InspireMD?

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%
InspireMD	-413.96%	-69.42%	-57.68%

Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than InspireMD.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380K	N/A	N/A
InspireMD	$10.85M	3.80	-$19.92M	-$0.73	N/A

Health Sciences Acquisitions Co. 2 has a beta of 0.09, indicating that its share price is 91% less volatile than the broader market. Comparatively, InspireMD has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market.

In the previous week, InspireMD had 2 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 2 mentions for InspireMD and 0 mentions for Health Sciences Acquisitions Co. 2. InspireMD's average media sentiment score of 0.63 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that InspireMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Health Sciences Acquisitions Co. 2	Neutral
InspireMD	Positive

InspireMD has a consensus price target of $4.50, indicating a potential upside of 411.36%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Health Sciences Acquisitions Co. 2.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Sciences Acquisitions Co. 2	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by insiders. Comparatively, 34.1% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

InspireMD beats Health Sciences Acquisitions Co. 2 on 8 of the 13 factors compared between the two stocks.

How does Health Sciences Acquisitions Co. 2 compare to PetVivo?

PetVivo (NASDAQ:PETV) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than PetVivo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	25.42	-$10.95M	-$0.38	N/A
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380K	N/A	N/A

In the previous week, PetVivo's average media sentiment score of 0.00 equaled Health Sciences Acquisitions Co. 2'saverage media sentiment score.

Company	Overall Sentiment
PetVivo	Neutral
Health Sciences Acquisitions Co. 2	Neutral

PetVivo has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its stock price is 91% less volatile than the broader market.

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 10.8% of PetVivo shares are owned by insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%

Summary

Health Sciences Acquisitions Co. 2 beats PetVivo on 6 of the 8 factors compared between the two stocks.

How does Health Sciences Acquisitions Co. 2 compare to Titan Medical?

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Health Sciences Acquisitions Co. 2 has a beta of 0.09, suggesting that its stock price is 91% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat Titan Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%
Titan Medical	N/A	-82.31%	-51.47%

Titan Medical has higher revenue and earnings than Health Sciences Acquisitions Co. 2.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380K	N/A	N/A
Titan Medical	$17.63M	1.13	$6.95M	$0.05	3.50

In the previous week, Titan Medical had 1 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 1 mentions for Titan Medical and 0 mentions for Health Sciences Acquisitions Co. 2. Health Sciences Acquisitions Co. 2's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
Health Sciences Acquisitions Co. 2	Neutral
Titan Medical	Neutral

Summary

Health Sciences Acquisitions Co. 2 and Titan Medical tied by winning 4 of the 8 factors compared between the two stocks.

How does Health Sciences Acquisitions Co. 2 compare to Retractable Technologies?

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than Retractable Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380K	N/A	N/A
Retractable Technologies	$37.15M	0.55	-$7.01M	-$0.21	N/A

Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%
Retractable Technologies	-41.11%	-17.15%	-9.33%

89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Health Sciences Acquisitions Co. 2's average media sentiment score of 0.00 equaled Retractable Technologies'average media sentiment score.

Company	Overall Sentiment
Health Sciences Acquisitions Co. 2	Neutral
Retractable Technologies	Neutral

Health Sciences Acquisitions Co. 2 has a beta of 0.09, suggesting that its share price is 91% less volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market.

Summary

Health Sciences Acquisitions Co. 2 beats Retractable Technologies on 5 of the 8 factors compared between the two stocks.

How does Health Sciences Acquisitions Co. 2 compare to Defiance Daily Target 2X Long LMND ETF?

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

Defiance Daily Target 2X Long LMND ETF has a net margin of 5.39% compared to Health Sciences Acquisitions Co. 2's net margin of 0.00%. Defiance Daily Target 2X Long LMND ETF's return on equity of 4.66% beat Health Sciences Acquisitions Co. 2's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Defiance Daily Target 2X Long LMND ETF	5.39%	4.66%	2.91%
Health Sciences Acquisitions Co. 2	N/A	N/A	-2.38%

In the previous week, Defiance Daily Target 2X Long LMND ETF's average media sentiment score of 0.00 equaled Health Sciences Acquisitions Co. 2'saverage media sentiment score.

Company	Overall Sentiment
Defiance Daily Target 2X Long LMND ETF	Neutral
Health Sciences Acquisitions Co. 2	Neutral

Defiance Daily Target 2X Long LMND ETF has higher revenue and earnings than Health Sciences Acquisitions Co. 2.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Defiance Daily Target 2X Long LMND ETF	$437.66M	0.01	$15.17M	$0.51	20.73
Health Sciences Acquisitions Co. 2	N/A	N/A	-$380K	N/A	N/A

Defiance Daily Target 2X Long LMND ETF has a beta of -11.15, suggesting that its share price is 1,215% less volatile than the broader market. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, suggesting that its share price is 91% less volatile than the broader market.

87.8% of Defiance Daily Target 2X Long LMND ETF shares are held by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. 6.6% of Defiance Daily Target 2X Long LMND ETF shares are held by insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Defiance Daily Target 2X Long LMND ETF beats Health Sciences Acquisitions Co. 2 on 5 of the 8 factors compared between the two stocks.

Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSAQ vs. The Competition

Export

Metric	Health Sciences Acquisitions Co. 2	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$43.73M	$41.12M	$6.68B	$11.99B
Dividend Yield	N/A	1.08%	2.67%	5.55%
P/E Ratio	N/A	15.89	24.06	23.63
Price / Sales	N/A	29.78	519.33	112.45
Price / Cash	N/A	18.87	42.23	54.60
Price / Book	-6.29	15.52	9.73	6.35
Net Income	-$380K	-$19.18M	$3.57B	$337.59M
7 Day Performance	-0.26%	-4.88%	-1.28%	-2.52%
1 Month Performance	-2.74%	-12.47%	1.38%	-0.03%
1 Year Performance	17.82%	-11.29%	23.93%	25.34%

Health Sciences Acquisitions Co. 2 Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSAQ Health Sciences Acquisitions Co. 2	N/A	$3.90 -2.3%	N/A	+27.9%	$43.73M	N/A	N/A	4
NSPR InspireMD	4.1595 of 5 stars	$0.96 -4.9%	$4.50 +368.7%	-64.8%	$44.97M	$10.85M	N/A	50
PETV PetVivo	N/A	$0.72 -10.5%	N/A	-6.4%	$26.09M	$1.05M	N/A	20	Gap Up
TMDIF Titan Medical	N/A	$0.20 -4.9%	N/A	-37.5%	$22.32M	$17.63M	N/A	50	Gap Up
RVP Retractable Technologies	N/A	$0.66 -1.5%	N/A	+0.7%	$19.68M	$37.15M	N/A	240

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSAQ) was last updated on 6/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health Sciences Acquisitions Co. 2 (HSAQ) Competitors

HSAQ vs. NSPR, PETV, TMDIF, RVP, and LMNX

How does Health Sciences Acquisitions Co. 2 compare to InspireMD?

Summary

How does Health Sciences Acquisitions Co. 2 compare to PetVivo?

Summary

How does Health Sciences Acquisitions Co. 2 compare to Titan Medical?

Summary

How does Health Sciences Acquisitions Co. 2 compare to Retractable Technologies?

Summary

How does Health Sciences Acquisitions Co. 2 compare to Defiance Daily Target 2X Long LMND ETF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSAQ vs. The Competition

Health Sciences Acquisitions Co. 2 Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health Sciences Acquisitions Co. 2 (HSAQ) Competitors

HSAQ vs. NSPR, PETV, TMDIF, RVP, and LMNX

How does Health Sciences Acquisitions Co. 2 compare to InspireMD?

Is HSAQ or NSPR more profitable?

Which has higher earnings and valuation, HSAQ or NSPR?

Which has more volatility and risk, HSAQ or NSPR?

Does the media prefer HSAQ or NSPR?

Do analysts rate HSAQ or NSPR?

Do insiders and institutionals believe in HSAQ or NSPR?

Summary

How does Health Sciences Acquisitions Co. 2 compare to PetVivo?

Which has higher earnings and valuation, PETV or HSAQ?

Does the media refer more to PETV or HSAQ?

Which has more risk & volatility, PETV or HSAQ?

Do institutionals and insiders believe in PETV or HSAQ?

Is PETV or HSAQ more profitable?

Summary

How does Health Sciences Acquisitions Co. 2 compare to Titan Medical?

Which has more risk and volatility, HSAQ or TMDIF?

Do institutionals & insiders have more ownership in HSAQ or TMDIF?

Is HSAQ or TMDIF more profitable?

Which has preferable earnings and valuation, HSAQ or TMDIF?

Does the media refer more to HSAQ or TMDIF?

Summary

How does Health Sciences Acquisitions Co. 2 compare to Retractable Technologies?

Which has preferable earnings & valuation, HSAQ or RVP?

Is HSAQ or RVP more profitable?

Do institutionals & insiders have more ownership in HSAQ or RVP?

Does the media prefer HSAQ or RVP?

Which has more volatility & risk, HSAQ or RVP?

Summary

How does Health Sciences Acquisitions Co. 2 compare to Defiance Daily Target 2X Long LMND ETF?

Is LMNX or HSAQ more profitable?

Does the media refer more to LMNX or HSAQ?

Which has better earnings and valuation, LMNX or HSAQ?

Which has more volatility and risk, LMNX or HSAQ?

Do insiders and institutionals have more ownership in LMNX or HSAQ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSAQ vs. The Competition

Health Sciences Acquisitions Co. 2 Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools